146 related articles for article (PubMed ID: 35953603)
1. Towards less invasive molecular diagnostics for endometrial cancer: massively parallel sequencing of endometrial lavage specimens in women attending for an office hysteroscopy.
Chao A; Wu KY; Lin CY; Lee YS; Huang HJ; Tang YH; Weng CH; Chao AS; Chang TC; Lai CH; Wu RC
J Mol Med (Berl); 2022 Sep; 100(9):1331-1339. PubMed ID: 35953603
[TBL] [Abstract][Full Text] [Related]
2. Genomic Analysis of Uterine Lavage Fluid Detects Early Endometrial Cancers and Reveals a Prevalent Landscape of Driver Mutations in Women without Histopathologic Evidence of Cancer: A Prospective Cross-Sectional Study.
Nair N; Camacho-Vanegas O; Rykunov D; Dashkoff M; Camacho SC; Schumacher CA; Irish JC; Harkins TT; Freeman E; Garcia I; Pereira E; Kendall S; Belfer R; Kalir T; Sebra R; Reva B; Dottino P; Martignetti JA
PLoS Med; 2016 Dec; 13(12):e1002206. PubMed ID: 28027320
[TBL] [Abstract][Full Text] [Related]
3. Massively parallel sequencing of endometrial lavage specimens for the detection of cancer-associated mutations in atypical and non-atypical endometrial hyperplasia.
Weng CH; Wu KY; Wang CJ; Huang HJ; Tsai CL; Lin CY; Ro A; Lai CH; Chao AS; Wu RC; Chao A
Front Med (Lausanne); 2022; 9():1090788. PubMed ID: 36619620
[TBL] [Abstract][Full Text] [Related]
4. Lavage of the Uterine Cavity for Molecular Detection of Müllerian Duct Carcinomas: A Proof-of-Concept Study.
Maritschnegg E; Wang Y; Pecha N; Horvat R; Van Nieuwenhuysen E; Vergote I; Heitz F; Sehouli J; Kinde I; Diaz LA; Papadopoulos N; Kinzler KW; Vogelstein B; Speiser P; Zeillinger R
J Clin Oncol; 2015 Dec; 33(36):4293-300. PubMed ID: 26552420
[TBL] [Abstract][Full Text] [Related]
5. Detection of somatic mutations in peritoneal lavages and plasma of endometrial cancer patients: A proof-of-concept study.
Mayo-de-Las-Casas C; Velasco A; Sanchez D; Martínez-Bueno A; Garzón-Ibáñez M; Gatius S; Ruiz-Miró M; Gonzalez-Tallada X; Llordella I; Tresserra F; Rodríguez S; Aldeguer E; Roman-Canal B; Bertran-Alamillo J; García-Peláez B; Rosell R; Molina-Vila MA; Matias-Guiu X
Int J Cancer; 2020 Jul; 147(1):277-284. PubMed ID: 31953839
[TBL] [Abstract][Full Text] [Related]
6. Analysis of endometrial lavage microbiota reveals an increased relative abundance of the plastic-degrading bacteria
Chao A; Chao AS; Lin CY; Weng CH; Wu RC; Yeh YM; Huang SS; Lee YS; Lai CH; Huang HJ; Tang YH; Lin YS; Wang CJ; Wu KY
Front Cell Infect Microbiol; 2022; 12():1031967. PubMed ID: 36439209
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of liquid-based genetic diagnosis of endometrial cancer.
Matsuura M; Yamaguchi K; Tamate M; Satohisa S; Teramoto M; Iwasaki M; Sugita S; Hasegawa T; Koubo R; Takane K; Ikenoue T; Furukawa Y; Saito T
Cancer Sci; 2018 Dec; 109(12):4025-4032. PubMed ID: 30289582
[TBL] [Abstract][Full Text] [Related]
8. Targeted next-generation sequencing for the detection of cancer-associated somatic mutations in adenomyosis.
Chao A; Wu RC; Lin CY; Lee LY; Tsai CL; Lee YS; Wang CJ
J Obstet Gynaecol; 2023 Dec; 43(1):2161352. PubMed ID: 36708516
[TBL] [Abstract][Full Text] [Related]
9. Genetic features of endometrioid-type endometrial carcinoma arising in uterine adenomyosis.
Yoshida H; Asami Y; Kobayashi-Kato M; Tanase Y; Uno M; Ishikawa M; Shiraishi K; Kato T
Virchows Arch; 2022 Jul; 481(1):117-123. PubMed ID: 34791535
[TBL] [Abstract][Full Text] [Related]
10. Molecular diagnosis of endometrial cancer from uterine aspirates.
Perez-Sanchez C; Colas E; Cabrera S; Falcon O; Sanchez-del-Río A; García E; Fernández-de-Castillo L; Muruzabal JC; Alvarez E; Fiol G; González C; Torrejón R; Moral E; Campos M; Repollés M; Carreras R; Jiménez-López J; Xercavins J; Aibar E; Perdones-Montero A; Lalanne E; Palicio M; Maes T; Rosell-Vives E; Nieto C; Ortega A; Pedrola N; Llauradó M; Rigau M; Doll A; Abal M; Ponce J; Gil-Moreno A; Reventós J
Int J Cancer; 2013 Nov; 133(10):2383-91. PubMed ID: 23649867
[TBL] [Abstract][Full Text] [Related]
11. Molecular biomarkers predicting early development of endometrial carcinoma: A pilot study.
Lupini L; Scutiero G; Iannone P; Martinello R; Bassi C; Ravaioli N; Soave I; Bonaccorsi G; Lanza G; Gafà R; Loizzi V; Negrini M; Greco P
Eur J Cancer Care (Engl); 2019 Nov; 28(6):e13137. PubMed ID: 31412428
[TBL] [Abstract][Full Text] [Related]
12. Detection of endometrial precancer by a targeted gynecologic cancer liquid biopsy.
Martignetti JA; Pandya D; Nagarsheth N; Chen Y; Camacho O; Tomita S; Brodman M; Ascher-Walsh C; Kolev V; Cohen S; Harkins TT; Schadt EE; Reva B; Sebra R; Dottino P
Cold Spring Harb Mol Case Stud; 2018 Dec; 4(6):. PubMed ID: 30301868
[TBL] [Abstract][Full Text] [Related]
13. Mutual exclusiveness between PIK3CA and KRAS mutations in endometrial carcinoma.
Kang S; Seo SS; Chang HJ; Yoo CW; Park SY; Dong SM
Int J Gynecol Cancer; 2008; 18(6):1339-43. PubMed ID: 18221484
[TBL] [Abstract][Full Text] [Related]
14. Cytological analysis of the distension fluid used during diagnostic office hysteroscopies in patients with suspected endometrial pathology.
Gerbaldo D; Papadia A; Cristoforoni P; Lorenzi P; Fulcheri E; Ragni N
Eur J Gynaecol Oncol; 2005; 26(2):215-8. PubMed ID: 15857035
[TBL] [Abstract][Full Text] [Related]
15. Strong correlation between molecular changes in endometrial carcinomas and concomitant hyperplasia.
Zauber P; Denehy TR; Taylor RR; Ongcapin EH; Marotta S; Sabbath-Solitare M
Int J Gynecol Cancer; 2015 Jun; 25(5):863-8. PubMed ID: 25768080
[TBL] [Abstract][Full Text] [Related]
16. High frequency of POLE mutations in synchronous endometrial and ovarian carcinoma.
Ishikawa M; Nakayama K; Nakamura K; Ono R; Yamashita H; Ishibashi T; Minamoto T; Iida K; Razia S; Ishikawa N; Kyo S
Hum Pathol; 2019 Mar; 85():92-100. PubMed ID: 30448219
[TBL] [Abstract][Full Text] [Related]
17. Targeted Genomic Profiling Reveals Recurrent KRAS Mutations in Mesonephric-like Adenocarcinomas of the Female Genital Tract.
Mirkovic J; McFarland M; Garcia E; Sholl LM; Lindeman N; MacConaill L; Dong F; Hirsch M; Nucci MR; Quick CM; Crum CP; McCluggage WG; Howitt BE
Am J Surg Pathol; 2018 Feb; 42(2):227-233. PubMed ID: 28984674
[TBL] [Abstract][Full Text] [Related]
18. Next-generation sequencing analysis of endometrial screening liquid-based cytology specimens: a comparative study to tissue specimens.
Akahane T; Kitazono I; Yanazume S; Kamio M; Togami S; Sakamoto I; Nohara S; Yokoyama S; Kobayashi H; Hiraki T; Suzuki S; Ueno S; Tanimoto A
BMC Med Genomics; 2020 Jul; 13(1):101. PubMed ID: 32652986
[TBL] [Abstract][Full Text] [Related]
19. Identification of a Gene Panel for Endometrioid Endometrial Cancer: a Possible Prognostic Value?
Malentacchi F; Turrini I; Sorbi F; Projetto E; Castiglione F; Vergoni F; Amunni G; Fambrini M; Petraglia F; Noci I; Pillozzi S
Reprod Sci; 2020 Feb; 27(2):592-598. PubMed ID: 32046431
[TBL] [Abstract][Full Text] [Related]
20. Tumor mutational analysis of GOG248, a phase II study of temsirolimus or temsirolimus and alternating megestrol acetate and tamoxifen for advanced endometrial cancer (EC): An NRG Oncology/Gynecologic Oncology Group study.
Myers AP; Filiaci VL; Zhang Y; Pearl M; Behbakht K; Makker V; Hanjani P; Zweizig S; Burke JJ; Downey G; Leslie KK; Van Hummelen P; Birrer MJ; Fleming GF
Gynecol Oncol; 2016 Apr; 141(1):43-8. PubMed ID: 27016228
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
